Carapeto F J, Winkelmann R K
Dermatologica. 1975;151(4):228-35. doi: 10.1159/000251340.
Determination in peripheral blood T and B lymphocytes performed in progressive systemic scleroderma (8 patients); dermatomyositis (5 patients); and inflammatory or mesenchymal scleroderma ('mixed' connective tissue disease) (5 patients) demonstrated a marked increase in peripheral B cells with T cell depression in patients with mesenchymal scleroderma. Patients with progressive systemic scleroderma and dermatomyositis demonstrated also a peripheral T depression, but no consistent changes in B cell population were found. The clear relationship between a B lymphocyte increase and elevated immunoglobulins, antinuclear and antiribonucleoprotein antibody and positive direct immunofluorescence of skin (basal membrane and blood vessels) defines inflammatory or mesenchymal scleroderma in which a disturbance in humoral immunity is involved. B lymphocyte determination can help to measure these changes in immunoreactivity.
对进行性系统性硬化症(8例患者)、皮肌炎(5例患者)和炎性或间质性硬化症(“混合性”结缔组织病)(5例患者)外周血T和B淋巴细胞的检测显示,间质性硬化症患者外周B细胞显著增加,同时T细胞减少。进行性系统性硬化症和皮肌炎患者也表现出外周T细胞减少,但未发现B细胞群体有一致变化。B淋巴细胞增加与免疫球蛋白升高、抗核抗体和抗核糖核蛋白抗体以及皮肤(基底膜和血管)直接免疫荧光阳性之间的明确关系,确定了涉及体液免疫紊乱的炎性或间质性硬化症。B淋巴细胞检测有助于衡量这些免疫反应性变化。